Comparison of intravitreal ziv-aflibercept and bevacizumab monotherapy in treatment-naive polypoidal choroidal vasculopathy

PURPOSE: To report the visual and anatomical outcomes of intravitreal ziv-aflibercept (IVZ) and bevacizumab (BVZ) monotherapy in treatment-naive polypoidal choroidal vasculopathy (PCV). METHODS: This was a retrospective case series of 16 eyes (8 eyes each in IVZ and BVZ groups). The study period was...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Sumit Randhir, Sahoo, Niroj Kumar, Goud, Nallamasa Rohit, Chhablani, Jay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6611246/
https://www.ncbi.nlm.nih.gov/pubmed/31238423
http://dx.doi.org/10.4103/ijo.IJO_638_18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6611246/
https://www.ncbi.nlm.nih.gov/pubmed/31238423
http://dx.doi.org/10.4103/ijo.IJO_638_18

Ejemplares similares